MART-1(27-35), human CAS NO.156251-11-5

MART-1(27-35), human CAS NO.156251-11-5

MART-1(27-35), human CAS NO.156251-11-5

MART-1(27-35), human CAS NO.156251-11-5

MART-1(27-35), human CAS NO.156251-11-5

MART-1(27-35), Human (CAS 193062-65-6) is a research-grade, HLA-A*0201-restricted epitope peptide with a molecular formula of C₄₉H₇₅N₁₃O₁₁ and a molecular weight of 1042.22 g/mol. Manufactured to ≥98% purity via RP-HPLC, it is a key tool for studying melanoma immunogenicity, T-cell activation, and cancer vaccine development.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
MART-1(27-35), Human
CAS NO.
156251-11-5
Appearance
White to off-white lyophilized powder
Molecular Formula
C37H67N9O11
Molecular Weight
814g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water (≥5 mg/mL), dilute acetic acid, or 0.01M PBS

Endotoxin< 1.0 EU/mg
Biological Activity
Functions as a melanoma-specific HLA-A*0201-restricted epitope, capable of inducing and activating cytotoxic T lymphocytes (CTLs) that target melanoma cells. Validated for use in cancer immunology research and vaccine development studies.
Storage Conditions
-20°C to -80°C in a desiccated environment, avoiding repeated freeze-thaw cycles.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

This peptide acts as a melanoma-specific antigenic epitope. It binds to the HLA-A*0201 molecule on antigen-presenting cells (APCs) to form a peptide-MHC complex. This complex is recognized by CD8⁺ cytotoxic T lymphocytes (CTLs), triggering CTL activation, proliferation, and targeted killing of MART-1-expressing melanoma cells. This mechanism is central to tumor immune surveillance and the development of cancer immunotherapies.


    2.PRODUCT INDICATIONS

    Melanoma tumor immunogenicity and T-cell response assays

    Preclinical development of peptide-based cancer vaccines

    Validation of HLA-A0201-restricted epitope presentation

    Immunotherapy efficacy testing in in vitro and in vivo models

    Mechanistic research into tumor escape from immune surveillance


    3.CLINICAL EFFICACY OF PRODUCT

    It reliably induces melanoma-specific CTL responses in HLA-A*0201-positive individuals.In vaccine trials, it has shown potential to shrink tumors and delay disease progression in melanoma patients.It has been used to monitor minimal residual disease and immune response persistence in post-treatment patients.It is a foundational component in the development of personalized cancer immunotherapies.


    4.DELIVERY & SHIPPING

    We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
    Professional and Secure Packaging
    Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
    We can also customize packaging according to customer needs.
    Shipping Methods 
    Main Method: International Air Freight

    We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.